Dexmedetomidine attenuates inflammation and pancreatic injury in a rat model of experimental severe acute pancreatitis via cholinergic anti-inflammatory pathway.
Journal
Chinese medical journal
ISSN: 2542-5641
Titre abrégé: Chin Med J (Engl)
Pays: China
ID NLM: 7513795
Informations de publication
Date de publication:
05 May 2020
05 May 2020
Historique:
pubmed:
9
4
2020
medline:
15
5
2021
entrez:
9
4
2020
Statut:
ppublish
Résumé
Excessive inflammatory responses play a critical role in the development of severe acute pancreatitis (SAP), and controlling such inflammation is vital for managing this often fatal disease. Dexmedetomidine has been reported to possess protective properties in inflammatory diseases. Therefore, this study aimed to investigate whether dexmedetomidine pre-treatment exerts an anti-inflammatory effect in rats with SAP induced by sodium taurocholate, and if so, to determine the potential mechanism. SAP was induced with sodium taurocholate. Rats received an intraperitoneal injection of dexmedetomidine 30 min before sodium taurocholate administration. α-bungarotoxin, a selective alpha-7 nicotinic acetylcholine receptor (α7nAchR) antagonist, was injected intra-peritoneally 30 min before dexmedetomidine administration. The role of the vagus nerve was evaluated by performing unilateral cervical vagotomy before the administration of dexmedetomidine. Efferent discharge of the vagal nerve was recorded by the BL-420F Data Acquisition & Analysis System. Six hours after onset, serum pro-inflammatory cytokine (tumor necrosis factor α [TNF-α] and interleukin 6 [IL-6]) levels and amylase levels were determined using an enzyme-linked immunosorbent assay and an automated biochemical analyzer, respectively. Histopathological changes in the pancreas were observed after hematoxylin and eosin staining and scored according to Schmidt criteria. Pre-treatment with dexmedetomidine significantly decreased serum levels of TNF-α, IL-6, and amylase, strongly alleviating pathological pancreatic injury in the rat model of SAP (TNF-α: 174.2 ± 30.2 vs. 256.1±42.4 pg/ml; IL-6: 293.3 ± 46.8 vs. 421.7 ± 48.3 pg/ml; amylase: 2102.3 ± 165.3 vs. 3186.4 ± 245.2 U/L). However, the anti-inflammatory and pancreatic protective effects were abolished after vagotomy or pre-administration of α-bungarotoxin. Dexmedetomidine also significantly increased the discharge frequency and amplitude of the cervical vagus nerve in the SAP rat model (discharge frequency: 456.8 ± 50.3 vs. 332.4 ± 25.1 Hz; discharge amplitude: 33.4 ± 5.3 vs. 20.5 ± 2.9 μV). Dexmedetomidine administration attenuated the systemic inflammatory response and local pancreatic injury caused by SAP in rats through the cholinergic anti-inflammatory pathway involving vagus- and α7nAChR-dependent mechanisms.
Sections du résumé
BACKGROUND
BACKGROUND
Excessive inflammatory responses play a critical role in the development of severe acute pancreatitis (SAP), and controlling such inflammation is vital for managing this often fatal disease. Dexmedetomidine has been reported to possess protective properties in inflammatory diseases. Therefore, this study aimed to investigate whether dexmedetomidine pre-treatment exerts an anti-inflammatory effect in rats with SAP induced by sodium taurocholate, and if so, to determine the potential mechanism.
METHODS
METHODS
SAP was induced with sodium taurocholate. Rats received an intraperitoneal injection of dexmedetomidine 30 min before sodium taurocholate administration. α-bungarotoxin, a selective alpha-7 nicotinic acetylcholine receptor (α7nAchR) antagonist, was injected intra-peritoneally 30 min before dexmedetomidine administration. The role of the vagus nerve was evaluated by performing unilateral cervical vagotomy before the administration of dexmedetomidine. Efferent discharge of the vagal nerve was recorded by the BL-420F Data Acquisition & Analysis System. Six hours after onset, serum pro-inflammatory cytokine (tumor necrosis factor α [TNF-α] and interleukin 6 [IL-6]) levels and amylase levels were determined using an enzyme-linked immunosorbent assay and an automated biochemical analyzer, respectively. Histopathological changes in the pancreas were observed after hematoxylin and eosin staining and scored according to Schmidt criteria.
RESULTS
RESULTS
Pre-treatment with dexmedetomidine significantly decreased serum levels of TNF-α, IL-6, and amylase, strongly alleviating pathological pancreatic injury in the rat model of SAP (TNF-α: 174.2 ± 30.2 vs. 256.1±42.4 pg/ml; IL-6: 293.3 ± 46.8 vs. 421.7 ± 48.3 pg/ml; amylase: 2102.3 ± 165.3 vs. 3186.4 ± 245.2 U/L). However, the anti-inflammatory and pancreatic protective effects were abolished after vagotomy or pre-administration of α-bungarotoxin. Dexmedetomidine also significantly increased the discharge frequency and amplitude of the cervical vagus nerve in the SAP rat model (discharge frequency: 456.8 ± 50.3 vs. 332.4 ± 25.1 Hz; discharge amplitude: 33.4 ± 5.3 vs. 20.5 ± 2.9 μV).
CONCLUSIONS
CONCLUSIONS
Dexmedetomidine administration attenuated the systemic inflammatory response and local pancreatic injury caused by SAP in rats through the cholinergic anti-inflammatory pathway involving vagus- and α7nAChR-dependent mechanisms.
Identifiants
pubmed: 32265428
doi: 10.1097/CM9.0000000000000766
pmc: PMC7213633
pii: 00029330-202005050-00011
doi:
Substances chimiques
Tumor Necrosis Factor-alpha
0
Dexmedetomidine
67VB76HONO
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1073-1079Références
Campion EW, Forsmark CE, Vege SS, Wilcox CM. Acute pancreatitis. N Engl J Med 2016; 375:1972–1981. doi: 10.1056/NEJMra1505202.
doi: 10.1056/nejmra1505202
Trikudanathan G, Wolbrink DRJ, van Santvoort HC, Mallery S, Freeman M, Besselink MG. Current concepts in severe acute and necrotizing pancreatitis: an evidence-based approach. Gastroenterology 2019; 156:1994–2007. doi: 10.1053/j.gastro.2019.01.269.
doi: 10.1053/j.gastro.2019.01.269
Schepers NJ, Bakker OJ, Besselink MG, Ahmed Ali U, Bollen TL, Gooszen HG, et al. Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis. Gut 2019; 68:1044–1051. doi: 10.1136/gutjnl-2017-314657.
doi: 10.1136/gutjnl-2017-314657
Garg PK, Singh VP. Organ failure due to systemic injury in acute pancreatitis. Gastroenterology 2019; 156:2008–2023. doi: 10.1053/j.gastro.2018.12.041.
doi: 10.1053/j.gastro.2018.12.041
Schneider L, Jabrailova B, Strobel O, Hackert T, Werner J. Inflammatory profiling of early experimental necrotizing pancreatitis. Life Sci 2015; 126:76–80. doi: 10.1016/j.lfs.2015.01.029.
doi: 10.1016/j.lfs.2015.01.029
Sarr MG. Minimal access necrosectomy: the newest advance of many in the treatment of necrotising pancreatitis. Gut 2018; 67:599–600. doi: 10.1136/gutjnl-2017-314660.
doi: 10.1136/gutjnl-2017-314660
Habtezion A, Gukovskaya AS, Pandol SJ. Acute pancreatitis: a multifaceted set of organelle and cellular interactions. Gastroenterology 2019; 156:1941–1950. doi: 10.1053/j.gastro.2018.11.082.
doi: 10.1053/j.gastro.2018.11.082
Uc A, Andersen DK, Borowitz D, Glesby MJ, Mayerle J, Sutton R, et al. Accelerating the drug delivery pipeline for acute and chronic pancreatitis-knowledge gaps and research opportunities: overview summary of a National Institute of Diabetes and Digestive and Kidney Diseases workshop. Pancreas 2018; 47:1180–1184. doi: 10.1097/MPA.0000000000001176.
doi: 10.1097/mpa.0000000000001176
Benarroch EE. Autonomic nervous system and neuroimmune interactions: new insights and clinical implications. Neurology 2019; 92:377–385. doi: 10.1212/WNL.0000000000006942.
doi: 10.1212/wnl.0000000000006942
Badke CM, Marsillio LE, Weese-Mayer DE, Sanchez-Pinto LN. Autonomic nervous system dysfunction in pediatric sepsis. Front Pediatr 2018; 6:280doi: 10.3389/fped.2018.00280.
doi: 10.3389/fped.2018.00280
Capcha J, Rodrigues CE, Moreira RS, Silveira MD, Dourado PM, Dos SF, et al. Wharton's jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation. Am J Physiol Regul Integr Comp Physiol 2019; 318:R135–R147. doi: 10.1152/ajpregu.00098.2018.
doi: 10.1152/ajpregu.00098.2018
Kanashiro A, Sonego F, Ferreira RG, Castanheira FV, Leite CA, Borges VF, et al. Therapeutic potential and limitations of cholinergic anti-inflammatory pathway in sepsis. Pharmacol Res 2017; 117:1–8. doi: 10.1016/j.phrs.2016.12.014.
doi: 10.1016/j.phrs.2016.12.014
Wang Z, Hou L, Yang H, Ge J, Wang S, Tian W, et al. Electroacupuncture pretreatment attenuates acute lung injury through alpha7 nicotinic acetylcholine receptor-mediated inhibition of HMGB1 release in rats after cardiopulmonary bypass. Shock 2018; 50:351–359. doi: 10.1097/SHK.0000000000001050.
doi: 10.1097/shk.0000000000001050
Ma J, Chen Q, Li J, Zhao H, Mi E, Chen Y, et al. Dexmedetomidine-mediated prevention of renal ischemia-reperfusion injury depends in part on cholinergic anti-inflammatory mechanisms. Anesth Analg 2018; doi: 10.1213/ANE.0000000000003820. [Epub ahead of print].
doi: 10.1213/ane.0000000000003820.
Inoue T, Abe C, Kohro T, Tanaka S, Huang L, Yao J, et al. Non-canonical cholinergic anti-inflammatory pathway-mediated activation of peritoneal macrophages induces Hes1 and blocks ischemia/reperfusion injury in the kidney. Kidney Int 2019; 95:563–576. doi: 10.1016/j.kint.2018.09.020.
doi: 10.1016/j.kint.2018.09.020
van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 2006; 130:1822–1830. doi: 10.1053/j.gastro.2006.02.022.
doi: 10.1053/j.gastro.2006.02.022
Ma P, Yu K, Yu J, Wang W, Ding Y, Chen C, et al. Effects of nicotine and vagus nerve in severe acute pancreatitis-associated lung injury in rats. Pancreas 2016; 45:552–560. doi: 10.1097/MPA.0000000000000575.
doi: 10.1097/mpa.0000000000000575
Shimizu S, Akiyama T, Kawada T, Sata Y, Mizuno M, Kamiya A, et al. Medetomidine, an alpha(2)-adrenergic agonist, activates cardiac vagal nerve through modulation of baroreflex control. Circ J 2012; 76:152–159. doi: 10.1253/circj.cj-11-0574.
doi: 10.1253/circj.cj-11-0574
Wu J, Li ST. Dexmedetomidine may produce extra protective effects on sepsis-induced diaphragm injury. Chin Med J 2015; 128:1407–1411. doi: 10.4103/0366-6999.156808.
doi: 10.4103/0366-6999.156808
Dardalas I, Stamoula E, Rigopoulos P, Malliou F, Tsaousi G, Aidoni Z, et al. Dexmedetomidine effects in different experimental sepsis in vivo models. Eur J Pharmacol 2019; 856:172401doi: 10.1016/j.ejphar.2019.05.030.
doi: 10.1016/j.ejphar.2019.05.030
Schneider L, Jabrailova B, Salem M, Kilk K, Hofer S, Brenner T, et al. Stimulation of central alpha2 receptors attenuates experimental necrotizing pancreatitis. Pancreas 2016; 45:260–264. doi: 10.1097/MPA.0000000000000474.
doi: 10.1097/mpa.0000000000000474
Laukkarinen JM, Van Acker GJ, Weiss ER, Steer ML, Perides G. A mouse model of acute biliary pancreatitis induced by retrograde pancreatic duct infusion of Na-taurocholate. Gut 2007; 56:1590–1598. doi: 10.1136/gut.2007.124230.
doi: 10.1136/gut.2007.124230
Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992; 215:44–56. doi: 10.1097/00000658-199201000-00007.
doi: 10.1097/00000658-199201000-00007
Moggia E, Koti R, Belgaumkar AP, Fazio F, Pereira SP, Davidson BR, et al. Pharmacological interventions for acute pancreatitis. Cochrane Database Syst Rev 2017; 4:D11384doi: 10.1002/14651858.CD011384.pub2.
doi: 10.1002/14651858.cd011384.pub2
Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421:384–388. doi: 10.1038/nature01339.
doi: 10.1038/nature01339
Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458–462. doi: 10.1038/35013070.
doi: 10.1038/35013070
Koopman FA, van Maanen MA, Vervoordeldonk MJ, Tak PP. Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis. J Intern Med 2017; 282:64–75. doi: 10.1111/joim.12626.
doi: 10.1111/joim.12626
Kimura K, Inaba Y, Watanabe H, Matsukawa T, Matsumoto M, Inoue H. Nicotinic alpha-7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non-alcoholic steatohepatitis. J Diabetes Investig 2019; 10:659–666. doi: 10.1111/jdi.12964.
doi: 10.1111/jdi.12964
Ri M, Fukatsu K, Miyakuni T, Yanagawa M, Murakoshi S, Yasuhara H, et al. Influences of vagotomy on gut ischemia-reperfusion injury in mice. Shock 2017; 47:646–652. doi: 10.1097/SHK.0000000000000783.
doi: 10.1097/shk.0000000000000783
Li-Sha G, Xing-Xing C, Lian-Pin W, De-Pu Z, Xiao-Wei L, Jia-Feng L, et al. Right cervical vagotomy aggravates viral myocarditis in mice via the cholinergic anti-inflammatory pathway. Front Pharmacol 2017; 8:25doi: 10.3389/fphar.2017.00025.
doi: 10.3389/fphar.2017.00025
Komegae EN, Farmer D, Brooks VL, McKinley MJ, McAllen RM, Martelli D. Vagal afferent activation suppresses systemic inflammation via the splanchnic anti-inflammatory pathway. Brain Behav Immun 2018; 73:441–449. doi: 10.1016/j.bbi.2018.06.005.
doi: 10.1016/j.bbi.2018.06.005
Caravaca AS, Gallina AL, Tarnawski L, Tracey KJ, Pavlov VA, Levine YA, et al. An effective method for acute vagus nerve stimulation in experimental inflammation. Front Neurosci 2019; 13:877doi: 10.3389/fnins.2019.00877.
doi: 10.3389/fnins.2019.00877